Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Company Announcements
AstraZeneca’s Imfinzi Shows Promise for NSCLC
13h ago
Premium
The Fly
AstraZeneca now sees FY24 core EPS to increase by mid teens percentage
1d ago
AZN
Premium
The Fly
AstraZeneca reports Q2 core EPS $1.98, consensus $1.95
1d ago
AZN
Premium
Company Announcements
AstraZeneca Reports Strong H1 2024 Growth
2d ago
Premium
The Fly
AstraZeneca put volume heavy and directionally bearish
2d ago
AZN
Premium
The Fly
AstraZeneca announces global license agreement with Pinetree Therapeutics
3d ago
AZN
Premium
The Fly
FDA Oncologic Drugs Advisory Committee Meeting
3d ago
AZN
Premium
The Fly
AstraZeneca initiated with a Buy at Bocom
8d ago
AZN
Premium
The Fly
Legend Biotech an attractive takeover target for biopharma, says Daiwa
11d ago
AZN
JNJ
Premium
The Fly
AstraZeneca completes acquisition of Amolyt Pharma
11d ago
AZN
Premium
Company Announcements
AstraZeneca Acquires Amolyt Pharma for $1.05 Billion
12d ago
Premium
Market News
Is AstraZeneca Stock (NASDAQ:AZN) Overbought or Worth the Valuation?
15d ago
AZN
JNJ
Premium
The Fly
AstraZeneca price target lowered to 13,100 GBp from 13,400 GBp at Guggenheim
15d ago
AZN
Premium
The Fly
AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at Barclays
16d ago
AZN
Premium
The Fly
AstraZeneca’s Tagrisso approved in EU as first-line treatment for lung cancer
21d ago
AZN
Premium
The Fly
AstraZeneca price target raised to 11,700 GBp from 11,300 GBp at Jefferies
24d ago
AZN
Premium
Company Announcements
AstraZeneca Shares Update and Global Reach
25d ago
Premium
The Fly
AstraZeneca’s MAA for sipavibart accepted by EMA for COVID-19 prevention
25d ago
AZN
Premium
The Fly
AstraZeneca’s Imfinzi, Lynparza recommended for approval in EU by CHMP
25d ago
AZN
Premium
Company Announcements
AstraZeneca’s Cancer Treatments Set for EU Approval
26d ago
Premium
The Fly
AstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
1M ago
AZN
Premium
Global Markets
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
1M ago
AZN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.